Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 10.37 is 27% above its 5-year average of 8.14, around the middle of its 5-year range (4.37–18.31).
As of the fiscal period ended Tuesday, June 30, 2026. 43.82% above its 12-month average of 7.21.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.37.
CURRENT RATIO
10.37
CURRENT RATIO AVG TTM
7.21
CURRENT RATIO AVG 3Y
7.34
CURRENT RATIO AVG 5Y
8.14
CURRENT RATIO AVG 10Y
7.20
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+43.82%
CURRENT VS 3Y AVG
+41.21%
CURRENT VS 5Y AVG
+27.34%
CURRENT VS 10Y AVG
+43.96%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.73
median of 861 covered companies
CURRENT VS SECTOR MEDIAN
+177.95%
vs the sector median at left
Sol-Gel Technologies Ltd.
Market Cap
$247.63M
Current Ratio
10.37
TTM Avg
7.21
3Y Avg
7.34
5Y Avg
8.14
Market Cap
$248.27M
Current Ratio
9.97
TTM Avg
9.81
3Y Avg
16.34
5Y Avg
20.09
Market Cap
$246.26M
Current Ratio
8.28
TTM Avg
3.73
3Y Avg
7.03
5Y Avg
8.20
Market Cap
$243.73M
Current Ratio
1.54
TTM Avg
1.17
3Y Avg
19.33
5Y Avg
29.22
Market Cap
$242.50M
Current Ratio
3.87
TTM Avg
3.17
3Y Avg
2.70
5Y Avg
2.15
Market Cap
$242.23M
Current Ratio
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.68
Market Cap
$241.04M
Current Ratio
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
Market Cap
$256.15M
Current Ratio
4.48
TTM Avg
4.80
3Y Avg
5.23
5Y Avg
5.23
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sol-Gel Technologies Ltd. (SLGL) | $247.63M | 10.37 | 7.21 | 7.34 | 8.14 |
| Upstream Bio, Inc. (UPB)vs › | $248.43M | 27.99 | 35.39 | 23.13 | 23.13 |
| Quantum-Si incorporated (QSI)vs › | $248.27M | 9.97 | 9.81 | 16.34 | 20.09 |
| Century Therapeutics, Inc. (IPSC)vs › | $246.26M | 8.28 | 3.73 | 7.03 | 8.20 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.73M | 1.54 | 1.17 | 19.33 | 29.22 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.50M | 3.87 | 3.17 | 2.70 | 2.15 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $242.23M | 4.70 | 7.13 | 7.51 | 5.68 |
| Galectin Therapeutics Inc. (GALT)vs › | $241.04M | 0.10 | 1.46 | 1.56 | 2.73 |
| Anika Therapeutics, Inc. (ANIK)vs › | $256.15M | 4.48 | 4.80 | 5.23 | 5.23 |
| Q32 Bio Inc. (QTTB)vs › | $238.71M | 20.30 | 4.91 | 4.89 | 6.73 |
Current Ratio
10.37
Quick Ratio
10.37
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 10.37 |
| 2026-03-31 | 8.84 |
| 2025-12-31 | 4.37 |
| 2025-09-30 | 5.15 |
| 2025-06-30 | 7.32 |
| 2025-03-31 | 5.12 |
| 2024-12-31 | 5.92 |
| 2024-09-30 | 5.81 |
| 2024-06-30 | 7.36 |
| 2024-03-31 | 6.89 |
| 2023-12-31 | 9.10 |
| 2023-09-30 | 10.09 |
| 2023-06-30 | 9.10 |
| 2023-03-31 | 10.37 |
| 2022-12-31 | 12.93 |
| 2022-09-30 | 18.31 |
| 2022-06-30 | 15.03 |
| 2022-03-31 | 11.09 |
| 2021-12-31 | 4.88 |
| 2021-09-30 | 5.05 |
| 2021-06-30 | 8.03 |
| 2021-03-31 | 10.83 |
| 2020-12-31 | 8.95 |
| 2020-09-30 | 8.55 |
| 2020-06-30 | 9.94 |
| 2020-03-31 | 9.51 |
| 2019-12-31 | 8.58 |
| 2019-09-30 | 7.80 |
| 2019-06-30 | 8.00 |
| 2019-03-31 | 8.29 |
| 2018-12-31 | 13.48 |
| 2018-09-30 | 15.96 |
| 2018-06-30 | 20.77 |
| 2018-03-31 | 43.20 |
| 2017-12-31 | 0.16 |
| 2017-09-30 | 0.25 |
| 2017-06-30 | 0.35 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.20 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
